Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Mike Fuller was quoted in “Biologic Fights Drive PTAB Drug Challenges To Record High”

February 8, 2018  | Michael L. Fuller

Partner Mike Fuller was quoted in “Biologic Fights Drive PTAB Drug Challenges To Record High,” an article posted in Law360. 

Excerpt: The number of challenges to drug patents at the Patent Trial and Appeal Board climbed to a record high in 2017, bolstered by an increasing number of petitions targeting patents covering biologics like the mega-blockbuster breast cancer drug Herceptin.

 

Read Full Article Here >> (Subscription Required)

Partner Mike Fuller was quoted in “Biologic Fights Drive PTAB Drug Challenges To Record High” Headshot

Michael L. Fuller

Mike Fuller is a technology enthusiast and widely regarded for his expertise in obtaining, licensing, and managing due diligence on patents involving molecular biology and computer science. Mike is a...

Related Links

Practice Areas

Industries

News & Insights

Blog - Biotechnology
Nov 2024
FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research
A recent article[1] authored by Haider J. Warraich, MD[2]; Troy Tazbaz[3]; and Robert M. Califf[4], MD in the Journal of the American Medical Association, reviews the history of artificial intelligence...
Blog - IP Practice
Dec 2024
Bound to Happen: Inherent Property Leaves No Question of Reasonable Expectation of Success
CYTIVA BIOPROCESS R&D AB V. JSR CORP. Before Prost, Taranto, and Hughes.  Appeal from the Patent Trial and Appeal Board. Summary: A claim limitation merely reciting an inherent property or...
News
Dec 2024
Sheila Swaroop Quoted in Managing IP on Professional Development for Litigators
In the Managing IP article “Pipeline Programmes: How Firms Encourage Juniors,” partner Sheila Swaroop discussed initiatives from the US Patent and Trademark Office and courts aimed at developing oral argument...